Latest Liquidity News

Intelligent Monitoring Group Limited has raised $20 million through a strategic equity placement to support its recent acquisitions and stabilize its financial position. The capital raise aims to broaden the investor base and enhance market liquidity ahead of the new year.

Thorney Technologies Limited (ASX, TEK) will resume trading on the ASX from 16 December 2025 following the lodgement of its Net Tangible Asset Backing, ending its recent suspension.

Li-FT Power Ltd has announced a strategic acquisition of Winsome Resources Limited and plans to acquire a controlling interest in the Galinée lithium property, aiming to create a leading Canadian lithium developer with enhanced scale and market presence.

MFF Capital Investments appoints Gerald Stack as CEO and Managing Director, signaling a strategic evolution with a proposed dividend increase to 10 cents per share.

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.

Acusensus Limited has successfully raised $30 million through a placement of 20 million shares at $1.50 each, supported by both existing and new investors. The capital injection aims to fuel business development, product innovation, and operational expansion.

Winsome Resources Limited (ASX, WR1) has had its trading suspension lifted immediately following its response to an ASX price query, restoring market access for investors.

Wellard Limited's shares have been suspended from trading on the ASX as the company moves toward official delisting, marking a significant shift for investors and the livestock export sector.

The ASX has suspended trading of Olympio Metals and Thorney Technologies shares due to delayed periodic report filings, highlighting ongoing compliance challenges for both companies.

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.

Biotron Limited’s BITO securities have been suspended from ASX trading due to non-compliance with key listing rules, raising questions about the company’s next steps.

Neuren Pharmaceuticals’ partner Acadia secures FDA approval for DAYBUE STIX, a new powder formulation of trofinetide offering greater flexibility for Rett syndrome patients. This milestone expands treatment options and sets the stage for increased royalty revenue in 2026.